Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment

Overview of attention for article published in BMC Cancer, November 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 1,523 followers.

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment https://t.co/sYiQoT4uZD

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment https://t.co/GGh7pmF9IP

Proliferation marker Ki67 has predictive and prognostic value in women with breast cancer receiving neoadjuvant chemo http://t.co/rFU669yb

Ki67, chemotherapy response & prognosis in breast cancer patients receiving neoadjuvant treatment http://t.co/6Dk2CtVN

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.